Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy

Neurology

Volumn 85, Issue 11, 2015, Pages 950-957

  French, Jacqueline A ^a   Krauss, Gregory L ^b   Wechsler, Robert T ^c   Wang, Xue Feng ^d   Diventura, Bree ^e   Brandt, Christian ^f   Trinka, Eugen ^g   O'Brien, Terence J ^h   Laurenza, Antonio ⁱ   Patten, Anna ^j   Bibbiani, Francesco ⁱ  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c Idaho Comprehensive Epilepsy Center   (United States)

^d CHONGQING MEDICAL UNIVERSITY   (China)

^e Epilepsy Study Consortium   (United States)

^f EPILEPSY CENTER BETHEL   (Germany)

^g PARACELSUS MEDICAL UNIVERSITY   (Austria)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ EISAI INC   (United States)

^j EISAI CO LTD   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; LAMOTRIGINE; PERAMPANEL; PLACEBO; TOPIRAMATE; VALPROIC ACID; ANTICONVULSIVE AGENT; PYRIDONE DERIVATIVE;

ABNORMAL BEHAVIOR; ADOLESCENT; ADULT; AGGRESSION; ANXIETY DISORDER; ARTICLE; BODY WEIGHT; CAUSE OF DEATH; CHRONIC CHOLECYSTITIS; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; CONTUSION; CONVULSION; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWNING; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPTIC STATE; FATIGUE; FEMALE; GENERALIZED EPILEPSY; HEADACHE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC GENERALIZED EPILEPSY; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL DISEASE; MOOD DISORDER; MORTALITY; MULTICENTER STUDY; NAUSEA; PERCEPTION; PRIMARY GENERALIZED TONIC CLONIC SEIZURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SOMNOLENCE; SUDDEN DEATH; SUICIDAL IDEATION; SUICIDE ATTEMPT; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERTIGO; VOMITING; WEIGHT GAIN; YOUNG ADULT; AGED; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; EPILEPSY, GENERALIZED; MIDDLE AGED; PROCEDURES; SEIZURES; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIDONES; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84946509524     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001930     Document Type: Article

References (33)

1. Rheims S, Ryvlin P. Pharmacotherapy for tonic-clonic seizures. Expert Opin Pharmacother 2014;15:1417-1426.
2. Hanada T, Yang H, Ido K, Laurenza A. AMPA Receptor Antagonists for the Treatment of CNS Disorders: Antiepileptics and Beyond. Frontiers in Clinical Drug Research (Volume 3): CNS and Neurological Disorders. Sharjah, UAE: Bentham Science Publishers; 2015:34-76.
3. Durmuller N, Craggs M, Meldrum BS. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res 1994;17: 167-174.
4. Kodama M, Yamada N, Sato K, et al. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-Derm hippocampal potentiation in the rat. Eur J Pharmacol 1999;374:11-19.
5. Wu T, Nagaya Y, Hanada T. Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model. Seizure 2014;23:732-739.
6. French JA, Krauss GL, Biton V, et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012;79:589-596.
7. French JA, Krauss GL, Steinhoff BJ, et al. Evaluation of adjunctive perampanel in patients with refractory partialonset seizures: results of randomized global phase III study 305. Epilepsia 2013;54:117-125.
8. Krauss GL, Serratosa JM, Villanueva V, et al. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 2012;78:1408-1415.
9. Steinhoff BJ, Ben-Menachem E, Ryvlin P, et al. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia 2013;54:1481-1489.
10. European Medicines Agency. Fycompa summary of product characteristics. Available at: http://www.ema.europa.eu/docs/ en-GB/document-library/EPAR-Product-Information/ human/002434/WC500130815.pdf. Accessed August 7, 2015.
11. Food and Drug Administration. Fycompa prescribing information. Available at: http://www.accessdata.fda.gov/ drugsatfda-docs/label/2015/202834s005lbl.pdf. Accessed August 7, 2015.
12. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22:489-501.
13. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-399.
14. Berg AT, Millichap JJ. The 2010 revised classification of seizures and epilepsy. Continuum 2013;19:571-597.
15. Holtkamp M, Kowski AB, Merkle H, Janz D. Long-Derm outcome in epilepsy with grand mal on awakening: forty years of follow-up. Ann Neurol 2014;75:298-302.
16. Senf P, Schmitz B, Holtkamp M, Janz D. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors. Neurology 2013;81:2128-2133.
17. Trinka E, Baumgartner S, Unterberger I, et al. Long-Derm prognosis for childhood and juvenile absence epilepsy. J Neurol 2004;251:1235-1241.
18. Unterberger I, Trinka E, Luef G, Bauer G. Idiopathic generalized epilepsies with pure grand mal: clinical data and genetics. Epilepsy Res 2001;44:19-25.
19. Höfler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E. Seizure outcome in 175 patients with juvenile myoclonic epilepsy: a long-Derm observational study. Epilepsy Res 2014;108:1817-1824.
20. Asadi-Pooya AA, Nikseresht A, Yaghoubi E, Nej M. Physical injuries in patients with epilepsy and their associated risk factors. Seizure 2012;21:165-168.
21. Hesdorffer DC, Tomson T, Benn E, et al. Combined analysis of risk factors for SUDEP. Epilepsia 2011;52: 1150-1159.
22. Hesdorffer DC, Tomson T, Benn E, et al. Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 2012;53: 249-252.
23. Monte CP, Arends JB, Tan IY, Aldenkamp AP, Limburg M, de KromMC. Sudden unexpected death in epilepsy patients: risk factors. A systematic review. Seizure 2007;16:1-7.
24. Tomson T, Beghi E, Sundqvist A, Johannessen SI. Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 2004;60:1-16.
25. Ryvlin P, Nashef L, Lhatoo SD, et al. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol 2013;12:966-977.
26. Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007;69:1751-1760.
27. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999;52:1330-1337.
28. Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA. Double-blind, placebocontrolled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005;65:1737-1743.
29. Biton V, Di Memmo J, Shukla R, et al. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. Epilepsy Behav 2010;19:352-358.
30. Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonicclonic seizures. Pediatrics 2006;118:e371-e378.
31. Gelisse P, Genton P, Kuate C, Pesenti A, Baldy-Moulinier M, Crespel A. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 2004;45:1282-1286.
32. Genton P, Gelisse P, Thomas P, Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-1109.
33. Thomas P, Valton L, Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006;129:1281-1292.